Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma

BACKGROUND AND AIMS: Although adjuvant transcatheter arterial chemoembolization (TACE) for resected hepatocellular carcinoma (HCC) may improve survival for some patients, identifying which patients can benefit remains challenging. The present study aimed to construct a survival prediction calculator...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Lei, Li, Chao, Wang, Ming-Da, Wang, Hong, Zhou, Ya-Hao, Zeng, Yong-Yi, Zhang, Wan-Guang, Chen, Ting-Hao, Wang, Nan-Ya, Li, Jie, Zhang, Yao-Ming, Wang, Yu, Gu, Wei-Min, Xing, Hao, Diao, Yong-Kang, Lau, Wan Yee, Zhang, Cheng-Wu, Pawlik, Timothy M., Shen, Feng, Huang, Dong-Sheng, Yang, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507320/
https://www.ncbi.nlm.nih.gov/pubmed/34641921
http://dx.doi.org/10.1186/s13045-021-01180-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507320/
https://www.ncbi.nlm.nih.gov/pubmed/34641921
http://dx.doi.org/10.1186/s13045-021-01180-5

Ejemplares similares